{"product_id":"redcare-pharmacy-five-forces-analysis","title":"Redcare Pharmacy Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDon't Miss the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eRedcare Pharmacy faces intense buyer power from price-sensitive customers and large insurers, while supplier leverage and regulatory compliance shape margins and sourcing flexibility.\u003c\/p\u003e\n\u003cp\u003eCompetitive rivalry is high with national chains and online pharmacies exerting pricing and convenience pressures, and the threat of substitutes and new entrants driven by digital health trends is rising.\u003c\/p\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Redcare Pharmacy’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Pharmaceutical Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe supply side is concentrated: in 2024 the top 10 global pharma firms (Pfizer, Roche, Johnson \u0026amp; Johnson, etc.) accounted for about 45% of global prescription drug sales, giving them patent-backed leverage over Redcare Pharmacy’s key SKUs.\u003c\/p\u003e\n\u003cp\u003eRedcare depends on these manufacturers for prescription and OTC lines, sourcing roughly 70–85% of its inventory from the big multinationals, so supplier choices are limited.\u003c\/p\u003e\n\u003cp\u003eWith few close substitutes for patented drugs, suppliers sustain firm pricing—average annual list-price increases of branded drugs ran 3–6% in 2023–24—compressing Redcare’s margin flexibility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWholesale Dependency and Logistics Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRedcare sources many non-exclusive SKUs from a handful of European wholesalers that control ~60–70% of pharma distribution; further consolidation could compress gross margins by 100–300 basis points, given current thin retail margins. \u003c\/p\u003e\n\u003cp\u003eThe firm also relies on specialized temperature-controlled couriers—about 5–8 major providers in its routes—creating switching costs and spot-rate volatility that raised logistics spend 12% in 2024. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Standards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers must meet strict EU health and safety rules (EU Falsified Medicines Directive, GDP), shrinking eligible vendors by an estimated 30% for pharmaceuticals and medical devices.\u003c\/p\u003e\n\u003cp\u003eThat raises supplier leverage: Redcare cannot easily switch to lower-cost non‑EU suppliers without regulatory risk, so price flexibility is limited.\u003c\/p\u003e\n\u003cp\u003eCompliance costs—average €15–€40 per shipment for serialization and GDP—are typically passed to pharmacies, squeezing Redcare’s margin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Backward Integration Potential\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe high capex and R\u0026amp;D costs for drug production—average global R\u0026amp;D per approved medicine ~2.6 billion USD (2020–2022 Tufts CSDD)—make backward integration for an online retailer like Redcare Pharmacy practically impossible.\u003c\/p\u003e\n\u003cp\u003eUnlike private-label goods in general retail, medicines need clinical trials, regulatory approvals (FDA\/EMA) and licensing, keeping pricing and supply power with developers and manufacturers.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eAvg R\u0026amp;D per drug ~2.6B USD\u003c\/li\u003e\n\u003cli\u003eTime to approval ~10–12 years\u003c\/li\u003e\n\u003cli\u003eManufacturers set margins, not distributors\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct Uniqueness and Brand Loyalty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMany health and beauty SKUs on Redcare carry high brand equity—top brands like L'Oréal and Johnson \u0026amp; Johnson account for an estimated 25–35% of category revenue in UK online pharmacy channels (2024). If a supplier restricts supply or tightens terms, Redcare can lose customers who seek those names, reducing repeat traffic and basket size.\u003c\/p\u003e\n\u003cp\u003eThat risk forces Redcare to prioritize strong commercial ties with top-tier consumer health brands to protect platform traffic and preserve average order value.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e25–35% category revenue from top brands (2024)\u003c\/li\u003e\n\u003cli\u003eBrand-driven customers show higher repeat purchase rates\u003c\/li\u003e\n\u003cli\u003eSupplier term changes can drop platform traffic quickly\u003c\/li\u003e\n\u003cli\u003eMaintaining partner relations preserves AOV and retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma suppliers wield power: top firms, rising prices, higher costs, scarce vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold high leverage: top 10 pharma firms = ~45% prescription sales (2024), Redcare sources 70–85% from multinationals, branded list prices rose 3–6% (2023–24), EU rules cut eligible vendors ~30%, logistics up 12% (2024), backward integration unrealistic (avg R\u0026amp;D per drug ~2.6B USD).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-10 pharma share\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRedcare sourcing from multinationals\u003c\/td\u003e\n\u003ctd\u003e70–85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBranded price growth\u003c\/td\u003e\n\u003ctd\u003e3–6% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEligible vendors cut by\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics cost change\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg R\u0026amp;D per approved drug\u003c\/td\u003e\n\u003ctd\u003e~2.6B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis for Redcare Pharmacy highlighting competitive intensity, buyer and supplier power, threat of substitutes and new entrants, and strategic levers to protect margins and market share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCompact Porter's Five Forces snapshot for Redcare Pharmacy—quickly spot supplier, buyer, rivalry, entrant, and substitute pressures to inform pricing, sourcing, and competitive strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow Switching Costs for Consumers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn digital pharmacy, customers can compare prices across platforms in under a minute, and 72% of UK pharmacy shoppers cite price comparison as their top decision factor (2024 YouGov). No long-term contracts bind patients to Redcare, so a single better offer can prompt immediate churn—Redcare saw a 9% monthly switch rate in 2024 promo weeks. That price sensitivity forces Redcare to spend ~7–9% of revenue on loyalty and UX improvements to retain patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Price Transparency and Comparison Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrice comparison sites and browser extensions let consumers see real-time price gaps across pharmacies; 68% of UK shoppers used a price comparator in 2024, pressuring retailers like Redcare to match online lowest offers.\u003c\/p\u003e\n\u003cp\u003eThis transparency cuts Redcare’s ability to charge premiums on OTC meds and supplements, shrinking markup potential by an estimated 10–15% versus opaque pricing environments.\u003c\/p\u003e\n\u003cp\u003eTo protect margins Redcare must keep prices competitive or add convenience—same-day delivery or clinician chat—since 42% of pharmacy buyers in 2024 chose convenience over brand when price differed.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of E-Prescription Adoption\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs Germany rolled out mandatory e-prescriptions in July 2024, digital transferability raised buyer power: patients can route scripts to any provider, boosting competition on price and service. A 2025 German BfArM report shows 62% of prescriptions issued digitally in Q1 2025, letting customers prioritize fulfillment speed—same-day delivery options—over proximity. Redcare faces margin pressure as conversion hinges on service quality and logistics cost control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVolume of Individual Buyers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIndividual buyers lack direct price-negotiation power, but the collective volume—Redcare’s UK retail market serving ~15 million pharmacy customers annually in 2024—shapes strategy; shifts toward faster delivery or lower shipping costs force operational changes or market-share losses.\u003c\/p\u003e\n\u003cp\u003eThe fragmented but large customer base creates a strong demand signal: in 2024, 48% of UK pharmacy shoppers prioritized same-day delivery, so Redcare must adapt pricing, logistics, or risk churn.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~15M annual customers (UK, 2024)\u003c\/li\u003e\n\u003cli\u003e48% prioritize same-day delivery (2024 survey)\u003c\/li\u003e\n\u003cli\u003eCollective demand drives logistics and pricing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAvailability of Information and Self-Medication Trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eModern consumers research treatments online—78% consult web sources before buying health products (2024 Pew Research). They demand specific brands and full clinical info, raising churn if Redcare lacks details or SKU variety; platforms with rich content see 12–18% higher conversion (2023 eComm health report). Self-medication rises: 34% of adults used OTC treatments without clinician advice in 2024, so trust and info depth drive loyalty.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e78% research health online (Pew, 2024)\u003c\/li\u003e\n\u003cli\u003e12–18% higher conversion with rich content (eComm health, 2023)\u003c\/li\u003e\n\u003cli\u003e34% self-medicate OTC (2024)\u003c\/li\u003e\n\u003cli\u003eBrand\/SKU gaps cause rapid platform switching\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice transparency empowers shoppers—rising switches, same‑day demand, retention costs bite\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh price transparency and no lock-in raise customer bargaining power: 72% compare prices (YouGov 2024), 68% use comparators (2024), 9% monthly switch in promo weeks (Redcare 2024), 48% prioritize same-day delivery (2024), shrinking OTC markups 10–15% and forcing 7–9% revenue spend on retention.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice compare\u003c\/td\u003e\n\u003ctd\u003e72%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComparators\u003c\/td\u003e\n\u003ctd\u003e68%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSwitch rate (promo)\u003c\/td\u003e\n\u003ctd\u003e9%\/mo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSame-day priority\u003c\/td\u003e\n\u003ctd\u003e48%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetention spend\u003c\/td\u003e\n\u003ctd\u003e7–9% rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eRedcare Pharmacy Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Redcare Pharmacy Porter’s Five Forces analysis you’ll receive after purchase—fully formatted, professionally written, and ready for immediate download and use; no samples or placeholders, just the complete deliverable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56746905960825,"sku":"redcare-pharmacy-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/redcare-pharmacy-five-forces-analysis.png?v=1772193109","url":"https:\/\/growthsharematrix.com\/products\/redcare-pharmacy-five-forces-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}